Skip to main content
. 2018 Jan 3;8(1):e019011. doi: 10.1136/bmjopen-2017-019011

Table 2.

Prevalence of multimorbidity

Full sample Asthma Diabetes Epilepsy Food allergy Juvenile arthritis P value
Baseline
 Any disorder 29 (58) 9 (64) 4 (44) 4 (50) 5 (63) 7 (64) 0.88
 Major depressive episode 12 (24) 4 (29) 2 (22) 1 (13) 1 (13) 4 (36) 0.74
 Separation anxiety 2 (4) 0 0 1 (13) 0 1 (9) 0.43
 Phobia* 15 (30) 6 (46) 1 (11) 1 (13) 3 (38) 4 (36) 0.35
 Generalised anxiety 6 (12) 0 0 2 (25) 2 (25) 2 (18) 0.11
 Attention-deficit hyperactivity 5 (10) 1 (7) 0 1 (13) 3 (38) 0 0.06
 Oppositional defiant 9 (18) 2 (14) 1 (11) 2 (25) 4 (50) 0 0.07
 Conduct 3 (6) 1 (7) 0 1 (13) 1 (13) 0 0.65
Six months
 Any disorder 21 (42) 9 (64) 1 (11) 4 (50) 2 (25) 5 (56) 0.10
 Major depressive episode 2 (4) 0 0 0 0 2 (22) 0.11
 Separation anxiety 3 (6) 2 (14) 0 1 (13) 0 0 0.56
 Phobia* 10 (20) 5 (36) 1 (11) 1 (13) 0 3 (33) 0.25
 Generalised anxiety 4 (8) 1 (7) 0 1 (13) 0 2 (22) 0.55
 Attention-deficit hyperactivity 3 (6) 0 0 0 2 (25) 1 (11) 0.09
 Oppositional defiant 6 (12) 2 (14) 0 2 (25) 2 (25) 0 0.31
 Conduct 4 (8) 1 (7) 0 2 (25) 1 (13) 0 0.33

*Includes generalised, non-generalised and specific phobias.

Results are the number (%) of children with multimorbidity. Fisher’s exact tests examined multimorbidity across the five physical conditions.